Patient safety associated with the surgical treatment of bone and soft tissue tumours during the COVID-19 pandemic-results from an observational study at the Oxford Sarcoma Service.
Raja Bhaskara RajasekaranSanjeev KotechaDuncan WhitwellThomas D A CoskerPaul CritchleyCharles Anton FriesDavid PigottChristopher L M H GibbonsAndrew CarrPublished in: International orthopaedics (2020)
In spite of the favourable results in majority of our patients, our study shows that patients with sarcoma operated at the height of the pandemic are at a risk of contracting COVID-19 and also having associated with mortality. The use of a COVID-free facility, surgery in patients < 60 60 years and in ASA I & II category are associated with better outcomes. If a second wave occurs, a serious consideration should be given to ways of minimising the risk of contracting COVID-19 in these vulnerable patients either by using COVID-free facilities or delaying treatment until peak of infection has passed.
Keyphrases
- coronavirus disease
- sars cov
- end stage renal disease
- patient safety
- newly diagnosed
- ejection fraction
- prognostic factors
- peritoneal dialysis
- type diabetes
- minimally invasive
- cardiovascular disease
- adipose tissue
- risk factors
- metabolic syndrome
- coronary artery disease
- atrial fibrillation
- insulin resistance
- quality improvement
- cardiovascular events
- coronary artery bypass